SEC Form 4 · accession 0001140361-17-009665
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Wareham
Director
Period of report
Feb 24, 2017
Accepted (ET)
Feb 28, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Feb 24, 2017 | M | 28,403 | $27.58 | A | 41,403 | D | |
| ResMed Common StockF1 | Feb 24, 2017 | S | 28,403 | $71.769 | D | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $27.58 | Feb 24, 2017 | M | 28,403 | D | Nov 11, 2012 | Nov 16, 2018 | ResMed Commmon Stock | 28,403 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $71.64 to $71.91. The price reported above reflects the weighted average sale price.
- F2Represents date options first became exercisable.